Theratechnologies ROCE
¿Qué es el ROCE de Theratechnologies?
El ROCE de Theratechnologies Inc. es -197.87%
¿Cuál es la definición de ROCE?
El retorno sobre el capital empleado (ROCE) es una relación financiera que mide la rentabilidad de una empresa y la eficiencia con la que se utiliza su capital.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de compañías en Sector Health Care en NASDAQ en comparadas con Theratechnologies
¿Qué hace Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Empresas con roce similar a Theratechnologies
- Reeds Inc tiene ROCE de -201.51%
- Intersect ENT Inc tiene ROCE de -200.74%
- Plurilock Security tiene ROCE de -199.71%
- Nimy Resources Ltd tiene ROCE de -199.29%
- Catheter Precision tiene ROCE de -199.22%
- T2 Biosystems tiene ROCE de -198.26%
- Theratechnologies tiene ROCE de -197.87%
- Tethyan Resource Corp tiene ROCE de -197.59%
- Pac Roots Cannabis tiene ROCE de -197.40%
- Acura Pharmaceuticals tiene ROCE de -196.81%
- Catasys tiene ROCE de -196.67%
- Odyssey Semiconductor Technologies tiene ROCE de -196.64%
- Nican tiene ROCE de -195.62%